Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on December 4th, 2015 by Agnieszka FredaChemistry
As a chemist you work with chemical compounds every day studying, mixing, separating, modifying. You know that we are made up of chemicals, and that if we zoom in close enough we will be visible as clusters of proteins, lipids, sugars, some metals and nonmetals. Continue reading “Are We Silently Suffering from Chemophobia?” »
Posted on December 1st, 2015 by Thibault GeouiPharma R&D
What is a Taxonomy?
A taxonomy is a system to classify objects or concepts. We all use such systems to bring order into different aspects of our lives, be it food in the refrigerator, clothes in the closet or files on our laptops. Continue reading “Taxonomy to answers” »
Posted on November 24th, 2015 by Joyce de LangenPharmacovigilance
On 16 April 2014, the new EU Clinical Trial Regulation on medicines for human use was adopted. The purpose of the new Clinical Trial Regulation is to create an environment that is favourable for conducting clinical trials, with the highest standards for patient safety, within the EU. Continue reading “French ePharmaDay 2015: New EU Clinical Trial Regulation and Data Transparency” »
Posted on November 23rd, 2015 by Agnieszka FredaPharma R&D
Have you ever tried googling ‘Pharma Industry’? Right after Wikipedia, page after page, you will find various articles referring to ‘Getting High on Fat Profits’, ‘Holding Big Pharma Accountable’. Continue reading “Express your “Pharma Pride”, Clearly Communicate Science” »
Posted on November 23rd, 2015 by David EvansChemistry
In a wide ranging interview, we find out what Reaxys PhD Prize Winner Dr. Hiroyuki Miyamura has been up to: Continue reading “David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura” »
Posted on November 18th, 2015 by Joanna AldredChemistry
I freely admit, life without chocolate is unthinkable. That my daily sugar rush may lead to diabetes or blocked arteries (among other things) is something I prefer not to think about. Continue reading “Can medicine mend a broken heart?” »
About this Blog
The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.
Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier, its affiliates and sponsors or its parent company, Reed Elsevier.